Reducing VEGFB accelerates NAFLD and insulin resistance in mice via inhibiting AMPK signaling pathway

Reducing VEGFB accelerates NAFLD and insulin resistance in mice via inhibiting AMPK signaling pathway

Abstract Objective Vascular endothelial growth factor B (VEGFB) was regarded to improve lipid metabolism and reduce obesity-related hyperlipidemia. Whether VEGFB participates in lipid metabolism in nonalcoholic fatty liver disease (NAFLD) has not been clear yet. This study investigated the involveme...

Full description

Bibliographic Details
Main Authors:	Rongrong Li, Yuqi Li, Xueling Yang, Yaorui Hu, Haining Yu, Yana Li
Format:	Article
Language:	English
Published:	BMC 2022-07-01
Series:	Journal of Translational Medicine
Subjects:	VEGFB NAFLD AMPK/ACC AMPK/SREBP1 Lipid metabolism
Online Access:	https://doi.org/10.1186/s12967-022-03540-2

Similar Items

Limonin, an AMPK Activator, Inhibits Hepatic Lipid Accumulation in High Fat Diet Fed Mice
by: Si-wei Wang, et al.
Published: (2022-01-01)

MD2 deficiency prevents high‐fat diet‐induced AMPK suppression and lipid accumulation through regulating TBK1 in non‐alcoholic fatty liver disease
by: Wu Luo, et al.
Published: (2022-03-01)

Modelling porcine NAFLD by deletion of leptin and defining the role of AMPK in hepatic fibrosis
by: Tan Tan, et al.
Published: (2023-09-01)

Kaempferol attenuates nonalcoholic fatty liver disease in type 2 diabetic mice via the Sirt1/AMPK signaling pathway
by: Na Li, et al.
Published: (2023-09-01)

SREBP and central nervous system disorders: genetic overlaps revealed by in silico analysis
by: Mary Jasmin Ang, et al.
Published: (2022-05-01)

Curcumin, quercetin and atorvastatin protected against the hepatic fibrosis by activating AMP-activated protein kinase
by: Razieh Kabirifar, et al.
Published: (2018-01-01)

HM-chromanone suppresses lipid accumulation by modulating AMPK/SREBP-1c pathway in ob/ob mice
by: Bo Ra Moon, et al.
Published: (2023-05-01)

Astragaloside IV Inhibits Triglyceride Accumulation in Insulin-Resistant HepG2 Cells via AMPK-Induced SREBP-1c Phosphorylation
by: Chunyi Wang, et al.
Published: (2018-04-01)

Crocin ameliorates hepatic steatosis through activation of AMPK signaling in db/db mice
by: Li Luo, et al.
Published: (2019-01-01)

Mangiferin Improves Hepatic Lipid Metabolism Mainly Through Its Metabolite-Norathyriol by Modulating SIRT-1/AMPK/SREBP-1c Signaling
by: Jian Li, et al.
Published: (2018-03-01)

Epigallocatechin-3-gallate ameliorates hepatic damages by relieve FGF21 resistance and promotion of FGF21–AMPK pathway in mice fed a high fat diet
by: Yuanyuan Zhang, et al.
Published: (2022-04-01)

Knockdown of VEGFB/VEGFR1 Signaling Promotes White Adipose Tissue Browning and Skeletal Muscle Development
by: Mingfa Ling, et al.
Published: (2022-07-01)

Dapagliflozin Alleviates Hepatic Steatosis by Restoring Autophagy via the AMPK-mTOR Pathway
by: Liuran Li, et al.
Published: (2021-05-01)

Aqueous extract of Artemisia capillaris improves non-alcoholic fatty liver and obesity in mice induced by high-fat diet
by: Meng Liang, et al.
Published: (2022-11-01)

Differential AMPK-mediated metabolic regulation observed in hibernation-style polymorphisms in Siberian chipmunks
by: Taito Kamata, et al.
Published: (2023-08-01)

The Dipeptidyl Peptidase-4 Inhibitor Teneligliptin Attenuates Hepatic Lipogenesis via AMPK Activation in Non-Alcoholic Fatty Liver Disease Model Mice
by: Takayasu Ideta, et al.
Published: (2015-12-01)

CPI-613 rewires lipid metabolism to enhance pancreatic cancer apoptosis via the AMPK-ACC signaling
by: Lixia Gao, et al.
Published: (2020-04-01)

Empagliflozin Regulates the AdipoR1/p-AMPK/p-ACC Pathway to Alleviate Lipid Deposition in Diabetic Nephropathy
by: Zhang Z, et al.
Published: (2021-01-01)

Novel mechanisms underlying anti-polycystic ovary like syndrome effects of electroacupuncture in rats: suppressing SREBP1 to mitigate insulin resistance, mitochondrial dysfunction and oxidative stress
by: Yan Peng, et al.
Published: (2020-10-01)

Exercise Intervention Mitigates Pathological Liver Changes in NAFLD Zebrafish by Activating SIRT1/AMPK/NRF2 Signaling
by: Yunyi Zou, et al.
Published: (2021-10-01)

Effect of A-769662, a direct AMPK activator, on Tlr-4 expression and activity in mice heart tissue
by: Maryam Rameshrad, et al.
Published: (2016-12-01)

Native polypeptide vglycin prevents nonalcoholic fatty liver disease in mice by activating the AMPK pathway
by: Chen-Cuang Yao, et al.
Published: (2020-10-01)

Regulation of Butyrate-Induced Resistance through AMPK Signaling Pathway in Human Colon Cancer Cells
by: Hee Young Yoo, et al.
Published: (2021-11-01)

AMPK Re-Activation Suppresses Hepatic Steatosis but its Downregulation Does Not Promote Fatty Liver Development
by: Nadia Boudaba, et al.
Published: (2018-02-01)

Polyphenol-rich Trapa quadrispinosa pericarp extract ameliorates high-fat diet induced non-alcoholic fatty liver disease by regulating lipid metabolism and insulin resistance in mice
by: Tunyu Jian, et al.
Published: (2019-11-01)

Electromagnetic fields ameliorate hepatic lipid accumulation and oxidative stress: potential role of CaMKKβ/AMPK/SREBP-1c and Nrf2 pathways
by: Mingming Zhai, et al.
Published: (2023-05-01)

Activation of AMPK Entails the Protective Effect of Royal Jelly against High-Fat-Diet-Induced Hyperglycemia, Hyperlipidemia, and Non-Alcoholic Fatty Liver Disease in Rats
by: Alaa Hasanain Felemban, et al.
Published: (2023-03-01)

VEGFB Promotes Myoblasts Proliferation and Differentiation through VEGFR1-PI3K/Akt Signaling Pathway
by: Mingfa Ling, et al.
Published: (2021-12-01)

Monkfish Peptides Mitigate High Fat Diet-Induced Hepatic Steatosis in Mice
by: Jiena Ye, et al.
Published: (2022-05-01)

Soy Isoflavones Ameliorate Fatty Acid Metabolism of Visceral Adipose Tissue by Increasing the AMPK Activity in Male Rats with Diet-Induced Obesity (DIO)
by: Jinlong Tan, et al.
Published: (2019-08-01)

Adiponectin Inhibits NLRP3 Inflammasome Activation in Nonalcoholic Steatohepatitis via AMPK-JNK/ErK1/2-NFκB/ROS Signaling Pathways
by: Zhixia Dong, et al.
Published: (2020-11-01)

AMPK protects endothelial cells against HSV-1 replication via inhibition of mTORC1 and ACC1
by: Heena Doshi, et al.
Published: (2023-10-01)

Hepatic Proteomic Changes and Sirt1/AMPK Signaling Activation by Oxymatrine Treatment in Rats With Non-alcoholic Steatosis
by: Hong Xu, et al.
Published: (2020-03-01)

Antidiabetic activity of Callicarpa nudiflora extract in type 2 diabetic rats via activation of the AMPK-ACC pathway
by: Wen-Yu Ma, et al.
Published: (2019-01-01)

AMPK-PPARγ-Cidec Axis Drives the Fasting-Induced Lipid Droplet Aggregation in the Liver of Obese Mice
by: Hongqiang Li, et al.
Published: (2022-07-01)

Lipid-Lowering Effects of a Novel Polysaccharide Obtained from Fuzhuan Brick Tea In Vitro
by: Wenjuan Yang, et al.
Published: (2023-09-01)

Over-expressions of <it>AMPK</it> subunits in ovarian carcinomas with significant clinical implications
by: Li Cuilan, et al.
Published: (2012-08-01)

Protopanaxadiol ameliorates NAFLD by regulating hepatocyte lipid metabolism through AMPK/SIRT1 signaling pathway
by: Yiping Li, et al.
Published: (2023-04-01)

Inhibition of NAMPT aggravates high fat diet-induced hepatic steatosis in mice through regulating Sirt1/AMPKα/SREBP1 signaling pathway
by: Ling-Fang Wang, et al.
Published: (2017-04-01)

miR-29 regulates metabolism by inhibiting JNK-1 expression in non-obese patients with type 2 diabetes mellitus and NAFLD
by: Lu Fangdong, et al.
Published: (2023-12-01)